Acura Pharmaceuticals, Inc.
ACUR
$0.02
$0.0191,900.00%
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Net Income | -42.10% | -2,404.41% | 75.65% | 67.99% | -- |
| Total Depreciation and Amortization | -52.60% | -66.22% | -71.59% | -54.21% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -123.74% | -123.88% | -105.85% | -82.16% | -- |
| Change in Net Operating Assets | 530.10% | 53,500.00% | -860.78% | -196.69% | -- |
| Cash from Operations | -238.46% | -210.12% | -1,177.34% | -16.34% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 4,533.33% | 4,533.33% | -45.13% | -80.44% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 0.00% | -78.57% | -78.57% | -- |
| Repurchase of Common Stock | -300.00% | -300.00% | -300.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -60.00% | 5,320.00% | -46.30% | -80.56% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -231.15% | -185.14% | -176.14% | -158.24% | -- |
